{"public_id":"cl_50c93e15004534aa3b73bc7379549a28","status":"active","superseded_by_public_id":null,"corpus_id":209180317,"text":"Irbesartan was well tolerated, with no observed difference in serious adverse event rates versus placebo.","confidence":0.93,"paper":{"corpus_id":209180317,"title":"Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial","url":"https://sah.borca.ai/papers/209180317"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.93,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_817f0ffbd584c92cfbd1f1c896727eed","name":"serious adverse events","description":"Clinically significant harmful events monitored as a safety outcome.","types":["safety outcome"],"url":"https://sah.borca.ai/concepts/co_817f0ffbd584c92cfbd1f1c896727eed"},{"public_id":"co_9b187ad6634cef838a05939407fcd6a6","name":"placebo","description":"An inactive comparison treatment used in the randomized trial.","types":["control"],"url":"https://sah.borca.ai/concepts/co_9b187ad6634cef838a05939407fcd6a6"},{"public_id":"co_aa02c9a30d7d19ceb03289e1febcc5be","name":"irbesartan","description":"A long-acting selective angiotensin II receptor blocker used here as the investigational treatment.","types":["drug"],"url":"https://sah.borca.ai/concepts/co_aa02c9a30d7d19ceb03289e1febcc5be"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_50c93e15004534aa3b73bc7379549a28"}